Q BioMed Inc. Stock Other OTC
Equities
QBIO
US74736N1054
Biotechnology & Medical Research
Sales 2021 | 0.2 0.27 | Sales 2022 | 0.28 0.39 | Capitalization | 1.35M 1.84M |
---|---|---|---|---|---|
Net income 2021 | -8M -10.89M | Net income 2022 | -2M -2.72M | EV / Sales 2021 | 79,967,019 x |
Net Debt 2021 | 2.71M 3.69M | Net Debt 2022 | 4.06M 5.53M | EV / Sales 2022 | 19,023,098 x |
P/E ratio 2021 |
-1.39
x | P/E ratio 2022 |
-0.2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.01% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 15-04-20 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 15-05-31 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 15-04-20 |
Rick Panicucci
BRD | Director/Board Member | 63 | 18-02-12 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |